Inhibition of cerebral vascular inflammation by brain endothelium-targeted oligodeoxynucleotide complex

Jing Hu, Daniah Al-Waili, Aishlin Hassan, Guo Chang Fan, Mei Xin, Jiukuan Hao

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The present study generated a novel DNA complex to specifically target endothelial NF-κB to inhibit cerebral vascular inflammation. This DNA complex (GS24-NFκB) contains a DNA decoy which inhibits NF-κB activity, and a DNA aptamer (GS-24), a ligand of transferrin receptor (TfR), which allows for targeted delivery of the DNA decoy into cells. The results indicate that GS24-NFκB was successfully delivered into a murine brain-derived endothelial cell line, bEND5, and inhibited inflammatory responses induced by tumor necrosis factor α (TNF-α) or oxygen-glucose deprivation/re-oxygenation (OGD/R) via down-regulation of the nuclear NF-κB subunit, p65, as well as its downstream inflammatory cytokines, inter-cellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule (VCAM-1). The inhibitory effect of the GS24-NFκB was demonstrated by a significant reduction in TNF-α or OGD/R induced monocyte adhesion to the bEND5 cells after GS24-NFκB treatment. Intravenous (i.v.) injection of GS24-'NFκB (15 mg/kg) was able to inhibit the levels of phoseph-p65 and VCAM-1 in brain endothelial cells in a mouse lipopolysaccharide (LPS)-induced inflammatory model in vivo. In conclusion, our approach using DNA nanotechnology for DNA decoy delivery could potentially be utilized for inhibition of inflammation in ischemic stroke and other neuro-inflammatory diseases affecting cerebral vasculature.

Original languageEnglish (US)
Pages (from-to)30-42
Number of pages13
JournalNeuroscience
Volume329
DOIs
StatePublished - Aug 4 2016

Fingerprint

Oligodeoxyribonucleotides
Encephalitis
Endothelium
Blood Vessels
Vascular Cell Adhesion Molecule-1
DNA
Endothelial Cells
Tumor Necrosis Factor-alpha
Nucleotide Aptamers
Oxygen
Inflammation
Glucose
Nanotechnology
Transferrin Receptors
Brain
Intravenous Injections
Lipopolysaccharides
Monocytes
Down-Regulation
Stroke

Keywords

  • Aptamer
  • Endothelial cells
  • Inflammation
  • Lipopolysaccharide
  • NF-κB
  • Oxygen-glucose deprivation

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Inhibition of cerebral vascular inflammation by brain endothelium-targeted oligodeoxynucleotide complex. / Hu, Jing; Al-Waili, Daniah; Hassan, Aishlin; Fan, Guo Chang; Xin, Mei; Hao, Jiukuan.

In: Neuroscience, Vol. 329, 04.08.2016, p. 30-42.

Research output: Contribution to journalArticle

Hu, Jing ; Al-Waili, Daniah ; Hassan, Aishlin ; Fan, Guo Chang ; Xin, Mei ; Hao, Jiukuan. / Inhibition of cerebral vascular inflammation by brain endothelium-targeted oligodeoxynucleotide complex. In: Neuroscience. 2016 ; Vol. 329. pp. 30-42.
@article{646f291fc5cd4568abbb3da5160b189b,
title = "Inhibition of cerebral vascular inflammation by brain endothelium-targeted oligodeoxynucleotide complex",
abstract = "The present study generated a novel DNA complex to specifically target endothelial NF-κB to inhibit cerebral vascular inflammation. This DNA complex (GS24-NFκB) contains a DNA decoy which inhibits NF-κB activity, and a DNA aptamer (GS-24), a ligand of transferrin receptor (TfR), which allows for targeted delivery of the DNA decoy into cells. The results indicate that GS24-NFκB was successfully delivered into a murine brain-derived endothelial cell line, bEND5, and inhibited inflammatory responses induced by tumor necrosis factor α (TNF-α) or oxygen-glucose deprivation/re-oxygenation (OGD/R) via down-regulation of the nuclear NF-κB subunit, p65, as well as its downstream inflammatory cytokines, inter-cellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule (VCAM-1). The inhibitory effect of the GS24-NFκB was demonstrated by a significant reduction in TNF-α or OGD/R induced monocyte adhesion to the bEND5 cells after GS24-NFκB treatment. Intravenous (i.v.) injection of GS24-'NFκB (15 mg/kg) was able to inhibit the levels of phoseph-p65 and VCAM-1 in brain endothelial cells in a mouse lipopolysaccharide (LPS)-induced inflammatory model in vivo. In conclusion, our approach using DNA nanotechnology for DNA decoy delivery could potentially be utilized for inhibition of inflammation in ischemic stroke and other neuro-inflammatory diseases affecting cerebral vasculature.",
keywords = "Aptamer, Endothelial cells, Inflammation, Lipopolysaccharide, NF-κB, Oxygen-glucose deprivation",
author = "Jing Hu and Daniah Al-Waili and Aishlin Hassan and Fan, {Guo Chang} and Mei Xin and Jiukuan Hao",
year = "2016",
month = "8",
day = "4",
doi = "10.1016/j.neuroscience.2016.04.033",
language = "English (US)",
volume = "329",
pages = "30--42",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Inhibition of cerebral vascular inflammation by brain endothelium-targeted oligodeoxynucleotide complex

AU - Hu, Jing

AU - Al-Waili, Daniah

AU - Hassan, Aishlin

AU - Fan, Guo Chang

AU - Xin, Mei

AU - Hao, Jiukuan

PY - 2016/8/4

Y1 - 2016/8/4

N2 - The present study generated a novel DNA complex to specifically target endothelial NF-κB to inhibit cerebral vascular inflammation. This DNA complex (GS24-NFκB) contains a DNA decoy which inhibits NF-κB activity, and a DNA aptamer (GS-24), a ligand of transferrin receptor (TfR), which allows for targeted delivery of the DNA decoy into cells. The results indicate that GS24-NFκB was successfully delivered into a murine brain-derived endothelial cell line, bEND5, and inhibited inflammatory responses induced by tumor necrosis factor α (TNF-α) or oxygen-glucose deprivation/re-oxygenation (OGD/R) via down-regulation of the nuclear NF-κB subunit, p65, as well as its downstream inflammatory cytokines, inter-cellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule (VCAM-1). The inhibitory effect of the GS24-NFκB was demonstrated by a significant reduction in TNF-α or OGD/R induced monocyte adhesion to the bEND5 cells after GS24-NFκB treatment. Intravenous (i.v.) injection of GS24-'NFκB (15 mg/kg) was able to inhibit the levels of phoseph-p65 and VCAM-1 in brain endothelial cells in a mouse lipopolysaccharide (LPS)-induced inflammatory model in vivo. In conclusion, our approach using DNA nanotechnology for DNA decoy delivery could potentially be utilized for inhibition of inflammation in ischemic stroke and other neuro-inflammatory diseases affecting cerebral vasculature.

AB - The present study generated a novel DNA complex to specifically target endothelial NF-κB to inhibit cerebral vascular inflammation. This DNA complex (GS24-NFκB) contains a DNA decoy which inhibits NF-κB activity, and a DNA aptamer (GS-24), a ligand of transferrin receptor (TfR), which allows for targeted delivery of the DNA decoy into cells. The results indicate that GS24-NFκB was successfully delivered into a murine brain-derived endothelial cell line, bEND5, and inhibited inflammatory responses induced by tumor necrosis factor α (TNF-α) or oxygen-glucose deprivation/re-oxygenation (OGD/R) via down-regulation of the nuclear NF-κB subunit, p65, as well as its downstream inflammatory cytokines, inter-cellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule (VCAM-1). The inhibitory effect of the GS24-NFκB was demonstrated by a significant reduction in TNF-α or OGD/R induced monocyte adhesion to the bEND5 cells after GS24-NFκB treatment. Intravenous (i.v.) injection of GS24-'NFκB (15 mg/kg) was able to inhibit the levels of phoseph-p65 and VCAM-1 in brain endothelial cells in a mouse lipopolysaccharide (LPS)-induced inflammatory model in vivo. In conclusion, our approach using DNA nanotechnology for DNA decoy delivery could potentially be utilized for inhibition of inflammation in ischemic stroke and other neuro-inflammatory diseases affecting cerebral vasculature.

KW - Aptamer

KW - Endothelial cells

KW - Inflammation

KW - Lipopolysaccharide

KW - NF-κB

KW - Oxygen-glucose deprivation

UR - http://www.scopus.com/inward/record.url?scp=84968866676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84968866676&partnerID=8YFLogxK

U2 - 10.1016/j.neuroscience.2016.04.033

DO - 10.1016/j.neuroscience.2016.04.033

M3 - Article

C2 - 27132231

AN - SCOPUS:84968866676

VL - 329

SP - 30

EP - 42

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

ER -